Lazard Asset Management
MDLN

Lazard Asset Management’s Medline Inc MDLN Stock Holding History

Lazard Asset Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
38,874
+12,426
+47% +$501K ﹤0.01% 1092
2026
Q1 		$1.18M Buy
26,448
+13,239
+100% +$585K ﹤0.01% 1108
2025
Q4 		$555K Buy
+13,209
New +$558K ﹤0.01% 1347

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Lazard Asset Management's MDLN Position: Q2 2026 in Review

Lazard Asset Management increased its Medline Inc (MDLN) stake by 47% in Q2 2026, buying an estimated $501K and bringing the position to 38,874 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Lazard Asset Management first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Lazard Asset Management held 38,874 shares of Medline Inc worth $1.53M as of Q2 2026.
  • Lazard Asset Management bought 12,426 Medline Inc shares in Q2 2026, an estimated $501K.
  • Medline Inc made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1092 holding.
  • Lazard Asset Management first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • 407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.